Saturday, August 23, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Wedbush Analyst Reiterates Outperform Rating for Rithm Capital with 13 Price Target

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Global supply chain
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Wedbush analyst Jay McCanless has once again expressed confidence in Rithm Capital (NYSE:RITM), reiterating an Outperform rating and a $13 price target. This reaffirmation underscores McCanless’s optimistic view of the company’s future prospects. According to TipRanks, a consensus of four analysts predicts an average 12-month price target of $11.75 for Rithm Capital, indicating a potential upside of 11.27% as of February 26, 2024.

RITM Stock Demonstrates Strong Performance: Trading Near 52-Week Highs and Above Moving Average

On February 26, 2024, RITM stock demonstrated strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend over a longer period of time.

The price of RITM shares increased by $0.01 since the market last closed, representing a 0.09% rise. The stock closed at $10.71, showing a slight increase during regular trading hours. Furthermore, RITM continued to show positive momentum as it rose by an additional $0.08 in after-hours trading.

Investors may view this positive price momentum as a bullish signal for RITM stock. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its past performance. Additionally, trading above its 200-day simple moving average indicates that the stock has been consistently trending upwards over a longer period of time.

It is important for investors to conduct thorough research and analysis before making any investment decisions. While past performance can provide some insights into the future potential of a stock, it is essential to consider other factors such as market conditions, company fundamentals, and industry trends.

RITM Stock Performance Analysis: Mixed Results for February 26, 2024

On February 26, 2024, RITM stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $3.79 billion, showing a significant increase of 86.85% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $1.42 billion.

In terms of net income, RITM reported a net income of $622.26 million for the past year, indicating a decrease of 34.81% compared to the previous year. In the last quarter, the company reported a net loss of $65.13 million, marking a substantial decrease of 130.11% since the previous quarter.

Earnings per share (EPS) for RITM were reported at $1.10 for the past year, showing a decrease of 38.67% compared to the previous year. In the last quarter, the company reported a negative EPS of -$0.18, which remained unchanged since the previous quarter.

Overall, RITM stock performances on February 26, 2024, reflected a mixed trend with significant increases in total revenue compared to the previous year, but decreases in net income and earnings per share. Investors may need to closely monitor the company’s financial performance and market conditions to make informed decisions about their investments in RITM stock.

Tags: RITM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mentorship

ZyVersa Therapeutics Makes Stunning Comeback After Trading Halt

Beverages Industry Markets and money (1)

Maintaining Positive Outlook on Keurig Dr Pepper Despite Recent Changes

Sleep

Deadline for LCNB Dividend Qualification Approaching

Recommended

Biotechnology Stock Bull Market

Analyst Douglas Tsao maintains bullish sentiment on Viridian Therapeutics

1 year ago
Healthcare-sector

Delta Apparel Resumes Stock Repurchase Program to Boost Market Position and Show Confidence in Future Prospects

2 years ago
Biotechnology Markets and money

Anixa Biosciences Initiates Treatment for Second Group in Phase 1 Clinical Trial for Revolutionary CART Therapy Targeting Ovarian Cancer

2 years ago
Industrial Metals and Mining Stock Exchange

Bullish Sentiment and Options Activity Insights into Rio Tintos Stock

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN Apple AVGO BA C CELH COIN Coinbase COST CRWD CTVA DELL DFS DIS DWAC Eli Lilly EQT GM GRFS IBM INTC JPM LLY META MSFT NFLX NIO NVDA NVO PARA PLTR PLUG SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

Waters Shares Surge on Strong Quarterly Performance

Lincoln National’s Q2 Earnings Beat Overshadows Revenue Concerns

Technical Headwinds Challenge Elanco’s Record-Breaking Quarter

Vipshop Navigates Conflicting Signals as Shareholder Returns Clash with Operational Pressures

Antero Resources: Divergent Analyst Views Highlight Natural Gas Market Crosscurrents

Market Sentiment on Ovintiv Stock Remains Deeply Divided

Trending

Arcutis Biotherapeutics Stock
Stocks

Insider Stock Sales Raise Questions at High-Flying Arcutis

by Andreas Sommer
August 23, 2025
0

While Arcutis Biotherapeutics celebrates a record-breaking financial quarter, a significant pattern of stock sales by a key...

Quanta Services Stock

Infrastructure Giant Quanta Services Navigates Market Crosscurrents

August 23, 2025
Oric Pharmaceuticals Inc Stock

Oric Pharmaceuticals Bets Future on Two Clinical Candidates Amid Market Skepticism

August 23, 2025
Waters Stock

Waters Shares Surge on Strong Quarterly Performance

August 23, 2025
Lincoln National Stock

Lincoln National’s Q2 Earnings Beat Overshadows Revenue Concerns

August 23, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Insider Stock Sales Raise Questions at High-Flying Arcutis August 23, 2025
  • Infrastructure Giant Quanta Services Navigates Market Crosscurrents August 23, 2025
  • Oric Pharmaceuticals Bets Future on Two Clinical Candidates Amid Market Skepticism August 23, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com